Coinspeaker JNJ Stock Down 1% Now, Johnson & Johnson to Produce 900M COVID-19 Vaccine Doses by Q1 2021Johnson & Johnson is planning to produce close to 1 billion COVID-19 doses by March 2021 if its human trials go well. Meanwhile, despite a small fall now, JNJ is slowly climbing higher and higher.JNJ Stock Down 1% Now, Johnson & Johnson to Produce 900M COVID-19 Vaccine Doses by Q1 2021